JULIO BELARMINO
BOBES GARCIA
Investigador ata 2022
Netherlands Cancer Institute
Amsterda, HolandaPublicacións en colaboración con investigadores/as de Netherlands Cancer Institute (1)
2019
-
Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort)
Acta Psychiatrica Scandinavica, Vol. 140, Núm. 3, pp. 283-290